Aberdeen Group’s Sagimet Biosciences SGMT Stock Holding History

Aberdeen Group’s Portfolio SGMT Stock Details SGMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.55M	Buy	+847,700	New	+$5.76M	0.01%	665

Other funds holding SGMT

FIA

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

MMA

Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return

APG

Abacus Planning Group Columbia, South Carolina $809M AUM 21.71% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

NFG

Nations Financial Group Cedar Rapids, Iowa $2.09B AUM 34.27% 1-Year Est. Return

PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Aberdeen Group's SGMT Position: Q2 2026 in Review

Aberdeen Group opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 847,700 shares worth $6.55M. The stake represents 0.01% of the portfolio and ranks #665 among its holdings.

14 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

Aberdeen Group held 847,700 shares of Sagimet Biosciences worth $6.55M as of Q2 2026.
Sagimet Biosciences was a new Aberdeen Group position in Q2 2026.
Sagimet Biosciences made up 0.01% of Aberdeen Group's portfolio in Q2 2026, its #665 holding.
14 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.